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1. Introduction 
The elongation of the growing peptide chain 
during its biosynthesis on the ribosome represents 
a complicated process involving the participation 
of several protein factors contained in the S-100 
supernatant fraction. The mechanism of their action 
is at present intensively investigated [ 1, 21 . This 
study provides evidence showing that tosylphenyl- 
alanyl chloromethane (TPCK, 1-chloro-4-phenyl-3- 
tosyl-amido-2-butanone) is a selective irreversible 
inhibitor of the complex of Sr S3 -factors in the cell- 
free protein-synthetizing system from B. sfearother- 
mophilus. As reported elsewhere, TPCK inhibits 
irreversibly also the T-factor from E. coli [3] . 
2. Xaterials and methods 
14C-L-phenylalanine (103 mCi/mmole) was pur- 
chased from the Institute for Research, Production, 
and Use of Radioisotopes, Prague, CSSR. PolyU and 
TPCK were from Calbiochem, USA, GTP from Koch- 
Light, England, and ATP from Reanal, Hungary. 
Sephadex G-25 Fine was a product of Pharmacia, 
Uppsala, Sweden. 
B. stearothemophilus, strain CCM 2 184 (a gene- 
rous gift of Dr. M. Kocur), was cultivated at 60’ 
with aeration in a medium of the same composition 
as described for E. coli [4] . The cells were harvested 
in the late logarithmic phase of growth, washed [5], 
frozen and then disintegrated by 3-min treatment in 
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a MSE Ultrasonic Generator. The washed ribosomes 
(20 mg/ml) were prepared according to Stenesh et 
al. [6]. The S-100 supernatant (10 mg of protein 
per ml) was prepared according to Algranati and 
Lengyel [5]. The &!&-fraction (i.e. the mixture 
of the St + Ss factor [7]) and the &-factor were 
prepared from the S-100 supernatant by fractiona- 
tion with (NH,), S04, acetone, and chromatography 
on a DEAE-Sephadex column according to a modi- 
fied method of Skoultchi et al. [7]. The details of 
the method will be described elsewhere. The SrSa- 
fraction was identified according to r4C-GTP bind- 
ing [8,9] . The !&-factor was identified on the basis 
of stimulation of the synthesis of polyphenylalanine 
from Phe-tRNA in the presence of the &&-fraction 
and on the basis of ribosome-dependent GTPase ac- 
tivity [lo]. The strict dependence of PolyU direct- 
ed polyphenylalanine formation upon Sr Ss-fraction 
and SZ factor is demonstrated in fig. 1. The Sr Ss- 
fraction (0.75 mg of protein per ml) and the SZ-fac- 
tor (0.3 mg of protein per ml) were stored in a buf- 
fer containing 0.01 M Tris-HCl (pH 7.4) 0.01 M /I- 
mercaptoethanol at 4”. 
The NH4Cl washed ribosomes from E. coli A 19 
(25 mg/ml) were prepared as reported earlier [4]. 
E. coli B tRNA was charged with 14C-phenylalanine 
according to von Ehrenstein and Lipmann [ 1 l] and 
filtered through a Sephadex G-25 column. 
Assay of polyphenylalanine formation. The in- 
corporation mixture contained 0.04 M TrisHCl (pH 
7.4) 0.01 M Mg (CH3C00)2, 0.16 M NH,Cl, 0.008 
M fl-mercaptoethanol, 250 E.cg of E. coli ribosomes, 
North-Holland Publishing Company - Amsterdam 
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Fig. 1. Requirement for Sr SJ and Sa complementary frac- 
tions in polyphenylalanine formation. Effects of increasing 
amounts of St& (a) and Sz (b) on polyphenylalanine syn- 
thesis in the presence of a constant amount of the other com- 
plementary fraction as indicated. The incubation mixture 
contained 104 pmole of 14C-Phe-tRNA and the remaining 
components as shown in Sect. 2. In the absence of St& and 
Ss, 2.5 pmole of phenylalanine was incorporated into hot 
TCA-insoluble precipitate. This amount was subtracted from 
all experimental values. 
20 pg of polyU, 2 mM GTP, 0.5 mM ATP, and 
r4C-Phe-tRNA, the original, control or inhibited 
S-100 (30~1) or SrSa-fraction (301.11) and the Sz- 
factor (10 ~1) as indicated. The total volume of the 
mixture was 0.1 ml. The reaction was started by 
adding GTP. The incubation period was 30 min at 
33’. The reaction was terminated with 5% TCA so- 
lution, and the hot TCA-insoluble material was 
counted in a Frieseke-Hoepfner counter [4]. 
Inhibition by TPCK. One ml of reaction mixture 
cantained: 0.5 mM TPCK, 1 mM GTP, 5% methanol 
and S-100 supematant, or S,Sa-fraction or !&-factor, 
or ribosomes as indicated. The incubation period 
was 3lh hr at 4”. The control sample was incubated 
only with 1 mM GTP and 5% methanol. As “original” 
is considered the sample not preincubated with any 
of the reagents. 
3. Results and discussion 
The preincubation of the S-100 supernatant frac- 
tion from B. steurothemophilus with 5 X 10V4 M 
TPCK leads to an almost complete inhibition of its 
ability to stimulate polyphenylalanine synthesis in 
the cell-free system directed by polyU (table 1). As 
shown, it is not decisive whether the synthesis starts 
Table 1 
Effect of tosylphenylalanyl chloromethane on the activity 
of the S-100 supematant fraction. 
(a) Polyphenylalanine synthesis 
from free phenylalanine (pmoles) 
S-100 supematant 
Original Control Inhibited 
- polyU 5.15 10.7 16.6 
+ polyU 418 365 62.8 
(b) Polyphenylalanine synthesis 
from Phe-tRNA (pmoles) 
- polyU 0.66 0.74 0.44 
+ polyU 30.7 27.1 1.5 
The incubation mixture contained 300 pg of protein of the 
S-100 supematant, buffer, ribosomes, polyU (where indi- 
cated), as given in sect. 2 and in addition in (a) 4 mM ATP, 
0.5 mM GTP, 0.25 PC of “C-phenylalanine, and 200 fig of 
E. coli tRNA, in (b) 92.5 pmole of r4C-Phe-tRNA. The in- 
corporation of phenylalanine into hot TCA-insoluble preci- 
pitate in the absence of S-100 was in (a) 25.3 pmole in the 
absence of polyU and 16.6 pmole in the presence of polyU, 
in (b) 4.2 pmole in the absence of poly U and 4.07 pmole in 
the presence of polyU. These amounts were subtracted from 
the corresponding experimental values. 
Table 2 
The irreversibility of the inhibitory effect of tosylphenyl- 
alanyl chloromethane on the S-100 supernatant fraction. 
Polyphenylalanine synthesis (pmoles) 
S-100 supernatant 
Original Control Inhibited 
Before 
Sephadex column 29.8 
After 
Sephadex column - 
28.1 2.12 
23.1 0.8 
150 ~1 of the control or inhibited S-100 fraction was filtered 
through 1.2 ml of Sephadex G-25 Fine in 0.02 M Tris-HCl 
buffer (pH 7.8), 0.01 M Mg (CHsCOO)a, 0.01 M p-mercapto- 
ethanol, and 5% methanol. 30 11 of the peak fraction of the 
control or inhibited S-100 fraction was used in the experi- 
ment after the filtration. The incubation mixture contained 
74 pmole of 14C-Phe-tRNA and the remaining components 
as given in sect. 2. The incorporation of phenylalanine into 
hot TCA-insoluble precipitate in the absence of S-100 super- 
natant was 3.28 pmole. This amount was subtracted from all 
experimental values. 
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Table 3 
The effect of tosylphenylalanyl chloromethane on the indk 
vidual components of the protein-synthesizing system. 
Polyphenylalanine synthesis (pmoles) 
Fraction treated Original Control Inhibited 
(a) S1 S3 
(b) Ribosomes 
19 14.7 1.27 
E. coli 
(c) s2 
(d) Ribosomes 
22.3 20.85 20.5 
20 15.2 16.1 
E. coli + S2 22.3 17.24 16.2 
(e) Ribosomes B. stea- 
rothermophilus 72.5 66.3 63 
The incubation mixture contained in (a) to (d) 22.5 /.rg of 
protein of the Sr Ss-fraction, 3 rg of protein of the S2-fac- 
tor, in (e) 125 c(g of protein of the S-100 fraction and 200 
pg of ribosomes from B. stearothermophilus, and further 
104 pmole of 14C-PhetRNA and the remaining components 
as given in sect. 2. The incorporation of phenylalanine into 
hot TCA-insoluble precipitate was 2.54 pmole in the ab- 
sence of all factors [(a), (c)], 0.24 pmole in the absence of 
ribosomes [(b), (d), (e)] , and these quantities were subtract- 
ed from all the corresponding experimental values. 
from free phenylalanine or from phenylalanyl-tRNA. 
In the first case the incorporation of phenylalanine 
is inhibited by 83%, in the second case even by 95%. 
This result also indicates that the process in phenyl- 
alanine synthesis affected by TPCK is not the syn- 
thesis of Phe-tRNA but that TPCK interferes with 
the subsequent reactions which take place during 
the de nova synthesis after aminoacyl-tRNA had 
been formed. 
The observed inhibitory effect of TPCK on the 
S- 100 supernatant system is most likely irreversible 
as follows from the results given in table 2. The fil- 
tration of the inhibited S-100 fraction through a 
Sephadex G-25 column in order to remove unreact- 
ed TPCK does not change the incorporation activity 
of this fraction. 
In other experiments we tested the effect of 
TPCK on the individual components of protein-syn- 
thetizing system, that is on the ribosomes from E. 
coli and B. stearothennophilus, on the Si S3 -fraction, 
and on the &-factor. The results given in table 3 pro- 
vide convincing evidence showing that it is the S1S3- 
fraction which is unambiguously and primarily affect- 
ed by the action of TPCK. The activity of neither 
the S2 -factor nor of the ribosomes from E. coli or 
from B. stearothetmophilus are influenced by this 
inhibitor under the conditions which lead to an in- 
hibition of the S1S3fraction by TPCK by 92%. 
Till now TPCK has been known as an effective 
inhibitor of certain proteolytic enzymes [ 121. The 
observation of its inhibitory effect on the SlS3 -frac- 
tion or the T-factor [3] during protein synthesis is 
thus surprising. A detailed elucidation of the mecha- 
nism of its effect in the process of synthesis of a 
new peptide on the ribosome will be the subject of 
our further studies. 
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